Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | UTRN | P46939 | 10/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12777236 | 0.92 | GAA (0.46) | HDAC6UTRNCYP1A2AHRMAPT | |
| SCHEMBL12777244 | 0.86 | MAPT (0.57) | HDAC6UTRNCYP1A2AHRMAPT | |
| SCHEMBL12776995 | 0.86 | HDAC6 (0.46) | HDAC6UTRNMAPTALDH1A1HPGD | |
| SCHEMBL12777066 | 0.86 | HDAC6 (0.46) | HDAC6UTRNMAPTALDH1A1HPGD | |
| SCHEMBL12777201 | 0.85 | KDM4E (0.48) | HDAC6UTRNMAPTALDH1A1HPGD | |
| SCHEMBL12777242 | 0.85 | RAB9A (0.46) | HDAC6UTRNCYP1A2AHRMAPT | |
| SCHEMBL12777228 | 0.85 | ALDH1A1 (0.50) | HDAC6UTRNCYP1A2AHRMAPT | |
| SCHEMBL12777240 | 0.84 | HPGD (0.53) | HDAC6UTRNCYP1A2AHRMAPT | |
| SCHEMBL12776999 | 0.83 | MAPT (0.48) | HDAC6UTRNCYP1A2MAPTESR1 | |
| SCHEMBL12777013 | 0.83 | MAPT (0.48) | HDAC6UTRNCYP1A2MAPTESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7901794-B2 | Material for light-emitting element and light emitting element | TORAY INDUSTRIES, INC. (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090066245-A1 | MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT | TORAY INDUSTRIES, INC. (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066245-A1 | MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT | PYM1, CRY1, S100A10 | HDAC6 4301/4885UTRN 4176/4885CYP1A2 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.